Sildenafil in idiopathic pulmonary fibrosis [1]

New England Journal of Medicine

Volumn 363, Issue 22, 2010, Pages 2169-2171

  Maher, Toby M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE; VASODILATOR AGENT;

COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; FIBROSING ALVEOLITIS; HUMAN; LETTER; LUNG ARTERY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE; WALKING; CLASSIFICATION; NOTE; PATHOPHYSIOLOGY; PATIENT SELECTION; METHODOLOGY; OUTCOME ASSESSMENT; STATISTICAL ANALYSIS;

HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; PATIENT SELECTION; PIPERAZINES; PURINES; SULFONES; VASODILATOR AGENTS; DATA INTERPRETATION, STATISTICAL; OUTCOME ASSESSMENT (HEALTH CARE); RESEARCH DESIGN;

EID: 78649440323     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1010408     Document Type: Letter

References (4)

1. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;129:746-52.
2. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-40.
3. The Idiopathic Pulmonary Fibrosis Clinical Research Network. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 2010;363:620-8.
4. Devaraj A, Wells AU, Meister MG, Corte TJ, Wort SJ, Hansell DM. Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology 2010;254:609-16.